FDA issues drug shortage rules

New FDA regulations require drugmakers, including makers of biologic drugs, to inform the agency of any plans to temporarily or permanently stop producing drugs considered in short supply.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Briefs: